Brief: Inspiremd Announces Submission Of Premarket Approval Application To FDA Seeking U.S. Regulatory Approval Of The Cguard™ Prime Carotid Stent System
16/09/2024 12:38
Sept 16 (Reuters) - InspireMD Inc NSPR.O :
* INSPIREMD ANNOUNCES SUBMISSION OF PREMARKET APPROVAL
APPLICATION
TO FDA SEEKING U.S. REGULATORY APPROVAL OF THE CGUARD™ PRIME
CAROTID STENT SYSTEM
* INSPIREMD INC - U.S. COMMERCIAL LAUNCH ANTICIPATED IN H1
2025 IF
APPROVED
Source text for Eikon: ID:nGNX3n7V1z
Further company coverage: NSPR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on InspireMD
See all newsInspireMD Inc reports results for the quarter ended June 30 - Earnings Summary
InspireMD Q2 revenue beats estimates on international demand
InspireMD Inc expected to post a loss of 20 cents a share - Earnings Preview
InspireMD Inc expected to post a loss of 20 cents a share - Earnings Preview
InspireMD Q1 revenue jumps 122%, beats estimates on product demand